ED0B0CDD31DD20E68725897900586A3C Hearing Summary

PUBLIC
BILL SUMMARY For SB23-041

HOUSE COMMITTEE ON HEALTH & INSURANCE
Date Mar 21, 2023
Location HCR 0112

SB23-041 - Postponed Indefinitely

10:05:51 AM

Representatives Amabile and Soper, co-prime bill sponsors, presented Senate Bill 23-041 concerning the authorization of prescription drugs for off-label use. The bill authorizes prescription drugs approved by the Food and Drug Administration (FDA) for off-label use.

10:10:04 AM

The committee asked
the co-prime bill sponsors questions on the bill.

10:24:14 AM

Mrs. Erin Meschke,
representing themself, testified in support of the bill and responded to
questions from the committee.

10:27:12 AM

Nancy Eason, representing
themself, testified

10:32:25 AM

Jack Teter, representing
Planned Parenthood of the Rocky Mountains, testified in opposition to the
bill.

Ms. Bethany Pray,
representing the Colorado Center on Law and Policy, testified in opposition
to the bill.

The committee
asked the panel questions.

10:53:04 AM

The co-prime bill
sponsors gave closing comments on the bill.

Committee members
commented on the bill.

10:57:38 AM	Motion	Refer Senate Bill 23-041 to the Committee of the Whole.
	Moved	Soper
	Seconded	Weinberg

	Brown	No
	Garcia	Excused
	Hartsook	Yes
	Lieder	No
	McCormick	No
	Ortiz	No
	Soper	Yes
	Titone	No
	Weinberg	Yes
	deGruy Kennedy	No
	Daugherty	No
		YES: 3 NO: 7 EXC: 1 ABS: 0 FINAL ACTION: FAIL

10:58:05 AM	Motion	Postpone Senate Bill 23-041 indefinitely using a reversal of the previous roll call. There was no objection to the use of the reverse roll call, therefore, the bill was postponed indefinitely.
	Moved	deGruy Kennedy
	Seconded	Ortiz

	Brown	Yes
	Garcia	Excused
	Hartsook	No
	Lieder	Yes
	McCormick	Yes
	Ortiz	Yes
	Soper	No
	Titone	Yes
	Weinberg	No
	deGruy Kennedy	Yes
	Daugherty	Yes
	Final	YES: 7 NO: 3 EXC: 1 ABS: 0 FINAL ACTION: PASS

SB23-041 - Postponed Indefinitely

Colorado General Assembly